Skip to content
Last sale
Nov 12, 2026 · -1.04%
Market cap
$24.64B
97.11M shares
Filings
693
$1.59B
Q2 2027+8.7% FY26 yoy
$213.70M
Q2 2027+27.3% FY26 yoy
$294.30M
Q2 2027+27.1% FY26 yoy
$492.50M
Q2 2027derived+25.0% FY26 yoy
$2.19
Q2 2027+27.9% FY26 yoy
$531.10M
Q2 2027+156.0% FY26 yoy
$24.64B
29.8×
4.0×
3.4×
3.80%
1.02%

Twelve months to Sep 30, 2026 · derived

Price

$253.714.87%$12.99past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$5.94BFY 2026
$5.94B0FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
PeriodEndedValueKindSource trail
FY 20262026-03-31$5,935,900,000reported
FY 20252025-03-31$5,459,500,000reported
FY 20242024-03-31$5,138,700,000reported
FY 20232023-03-31$4,536,266,000 revisedreported
FY 20222022-03-31$4,223,403,000 revisedreported
FY 20212021-03-31$3,107,519,000reported
FY 20202020-03-31$3,030,895,000reported
FY 20192019-03-31$2,782,170,000reported
FY 20182018-03-31$2,619,996,000reported
FY 20172017-03-31$2,612,756,000reported

Capital returns

Dividends and buybacks · FY2017 to FY2026
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2026$241.80M$235.50M$477.30M$2.4697.60M sh−0.8%49.1%
FY2025$219.90M$211.30M$431.20M$2.2398.37M sh−0.5%55.4%
FY2024$200.60M$11.80M$212.40M$2.0398.90M sh+0.3%34.6%
FY2023$183.50M$308.57M$492.06M$1.8498.65M sh−1.4%124.6%
FY2022$163.17M$55.78M$218.95M$1.69100.08M sh+17.2%55.1%

Segments

Revenue by Segments, FY2019 to FY2026FY2019AST · FY2019 · $555.13MLife Sciences · FY2019 · $378.56MHealthcare · FY2019 · $1.85BFY2020AST · FY2020 · $627.15MLife Sciences · FY2020 · $416.94MHealthcare · FY2020 · $1.99BFY2021AST · FY2021 · $685.91MLife Sciences · FY2021 · $467.55MHealthcare · FY2021 · $1.95BFY2023Healthcare Segment · FY2023 · $3.09BAST · FY2023 · $914.43MLife Sciences · FY2023 · $536.70MHealthcare · FY2023 · $3.09BFY2024Healthcare Segment · FY2024 · $3.61BAST · FY2024 · $954.00MLife Sciences · FY2024 · $571.70MHealthcare · FY2024 · $3.61BFY2025Healthcare Segment · FY2025 · $3.88BAST · FY2025 · $1.04BLife Sciences · FY2025 · $542.30MHealthcare · FY2025 · $3.88BFY2026Healthcare Segment · FY2026 · $4.21BAST · FY2026 · $1.14BLife Sciences · FY2026 · $588.80M
LineFY2026ShareChange
Healthcare Segment$4.21B71%+8.5%
AST$1.14B19%+9.6%
Life Sciences$588.80M9.9%+8.6%
Healthcare———
Total$5.94B

From the 10-K filed May 29, 2026STE

Orthopedic, prosthetic & surgical appliances & supplies

Steris PLC is the 5th largest of the 29 covered companies the SEC files under this code, by revenue. SIC 3842

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Steris PLC · CIK 1757898 · Engraved from SEC EDGAR